chr11-117381773-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_014956.5(CEP164):c.1482T>C(p.Pro494Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.928 in 1,600,984 control chromosomes in the GnomAD database, including 690,587 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.93 ( 65745 hom., cov: 32)
Exomes 𝑓: 0.93 ( 624842 hom. )
Consequence
CEP164
NM_014956.5 synonymous
NM_014956.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.912
Publications
16 publications found
Genes affected
CEP164 (HGNC:29182): (centrosomal protein 164) This gene encodes a centrosomal protein involved in microtubule organization, DNA damage response, and chromosome segregation. The encoded protein is required for assembly of primary cilia and localizes to mature centrioles. Defects in this gene are a cause of nephronophthisis-related ciliopathies. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
CEP164 Gene-Disease associations (from GenCC):
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- nephronophthisis 15Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, G2P
- Senior-Loken syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 11-117381773-T-C is Benign according to our data. Variant chr11-117381773-T-C is described in ClinVar as Benign. ClinVar VariationId is 260475.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.912 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.949 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CEP164 | NM_014956.5 | c.1482T>C | p.Pro494Pro | synonymous_variant | Exon 13 of 33 | ENST00000278935.8 | NP_055771.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CEP164 | ENST00000278935.8 | c.1482T>C | p.Pro494Pro | synonymous_variant | Exon 13 of 33 | 1 | NM_014956.5 | ENSP00000278935.3 | ||
| CEP164 | ENST00000533675.5 | n.1737T>C | non_coding_transcript_exon_variant | Exon 9 of 27 | 2 | |||||
| CEP164 | ENST00000533706.5 | n.806T>C | non_coding_transcript_exon_variant | Exon 6 of 27 | 5 |
Frequencies
GnomAD3 genomes AF: 0.928 AC: 141215AN: 152126Hom.: 65683 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
141215
AN:
152126
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.908 AC: 203366AN: 223894 AF XY: 0.907 show subpopulations
GnomAD2 exomes
AF:
AC:
203366
AN:
223894
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.928 AC: 1344930AN: 1448740Hom.: 624842 Cov.: 60 AF XY: 0.926 AC XY: 666561AN XY: 719464 show subpopulations
GnomAD4 exome
AF:
AC:
1344930
AN:
1448740
Hom.:
Cov.:
60
AF XY:
AC XY:
666561
AN XY:
719464
show subpopulations
African (AFR)
AF:
AC:
31658
AN:
33204
American (AMR)
AF:
AC:
37809
AN:
43250
Ashkenazi Jewish (ASJ)
AF:
AC:
22818
AN:
25738
East Asian (EAS)
AF:
AC:
34048
AN:
39180
South Asian (SAS)
AF:
AC:
72584
AN:
83864
European-Finnish (FIN)
AF:
AC:
49850
AN:
52280
Middle Eastern (MID)
AF:
AC:
5111
AN:
5646
European-Non Finnish (NFE)
AF:
AC:
1035932
AN:
1105782
Other (OTH)
AF:
AC:
55120
AN:
59796
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
5213
10426
15638
20851
26064
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
21510
43020
64530
86040
107550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.928 AC: 141335AN: 152244Hom.: 65745 Cov.: 32 AF XY: 0.927 AC XY: 68992AN XY: 74440 show subpopulations
GnomAD4 genome
AF:
AC:
141335
AN:
152244
Hom.:
Cov.:
32
AF XY:
AC XY:
68992
AN XY:
74440
show subpopulations
African (AFR)
AF:
AC:
39732
AN:
41544
American (AMR)
AF:
AC:
13635
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
3075
AN:
3470
East Asian (EAS)
AF:
AC:
4374
AN:
5162
South Asian (SAS)
AF:
AC:
4113
AN:
4816
European-Finnish (FIN)
AF:
AC:
10086
AN:
10614
Middle Eastern (MID)
AF:
AC:
267
AN:
294
European-Non Finnish (NFE)
AF:
AC:
63342
AN:
68030
Other (OTH)
AF:
AC:
1934
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
515
1031
1546
2062
2577
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2988
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Nephronophthisis 15 Benign:2
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.